View in EDS HTML Full Text PDF Full Text

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

Saved in:
Bibliographic Details
Title: Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
Authors: Jensen TO; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Grandits GA; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA., Jain MK; Southwestern Medical Center, University of Texas, Dallas, Texas  USA., Murray TA; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA., Grund B; School of Statistics, University of Minnesota, Minneapolis, Minnesota, USA., Shaw-Saliba K; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Matthay MA; Division of Pulmonary and Critical Care Medicine, University of California SanFrancisco, San Francisco, California, USA., Abassi M; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Ardelt M; Division of Pulmonary and Critical Care Medicine, University of California SanFrancisco, San Francisco, California, USA., Baker JV; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; Division of Infectious Diseases, Hennepin Healthcare, Minneapolis, Minnesota, USA., Chen P; Women's Guild Lung Institute, Department of medicine and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Dewar RL; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Goodman AL; Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom.; Department of Infectious Diseases, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom., Hatlen TJ; Lundquist Institute, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA., Highbarger HC; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Holodniy M; Department of Medicine, Infectious Diseases, Stanford University, Stanford, California, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA., Lallemand P; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Laverdure S; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Leshnower BG; Division of Cardiothoracic Surgery, Emory School of Medicine, Atlanta, Georgia, USA., Looney D; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA., Moschopoulos CD; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Mugerwa H; Joint Clinical Research Centre, Kampala, Uganda., Murray DD; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Mylonakis E; Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA., Nagy-Agren S; Salem Veterans Affairs Medical Center, Virginia, USA.; Virginia Tech Carilion School of Medicine, Virginia, USA., Rehman MT; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Rupert A; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Stevens RA; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Turville S; The Kirby Institute, University of New South Wales, Sydney, Australia., Weintrob A; Infectious Diseases Section, Washington DC Veterans Affairs Medical Center, Washington, District of Columbia, USA., Wick K; Department of Internal Medicine, University of California Davis, Davis, California, USA., Lundgren J; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Ko ER; Division of General Internal Medicine, Department of Medicine, Duke University Health System, Durham, North Carolina, USA.
Corporate Authors: ACTIV-3/TICO Study Group
Source: The Journal of infectious diseases [J Infect Dis] 2024 Mar 14; Vol. 229 (3), pp. 671-679.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37948759
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jensen+TO%22">Jensen TO</searchLink>; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Grandits+GA%22">Grandits GA</searchLink>; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Jain+MK%22">Jain MK</searchLink>; Southwestern Medical Center, University of Texas, Dallas, Texas  USA.<br /><searchLink fieldCode="AU" term="%22Murray+TA%22">Murray TA</searchLink>; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Grund+B%22">Grund B</searchLink>; School of Statistics, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Shaw-Saliba+K%22">Shaw-Saliba K</searchLink>; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Matthay+MA%22">Matthay MA</searchLink>; Division of Pulmonary and Critical Care Medicine, University of California SanFrancisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Abassi+M%22">Abassi M</searchLink>; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Ardelt+M%22">Ardelt M</searchLink>; Division of Pulmonary and Critical Care Medicine, University of California SanFrancisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Baker+JV%22">Baker JV</searchLink>; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; Division of Infectious Diseases, Hennepin Healthcare, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Chen+P%22">Chen P</searchLink>; Women's Guild Lung Institute, Department of medicine and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Dewar+RL%22">Dewar RL</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Goodman+AL%22">Goodman AL</searchLink>; Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom.; Department of Infectious Diseases, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hatlen+TJ%22">Hatlen TJ</searchLink>; Lundquist Institute, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Highbarger+HC%22">Highbarger HC</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Holodniy+M%22">Holodniy M</searchLink>; Department of Medicine, Infectious Diseases, Stanford University, Stanford, California, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Lallemand+P%22">Lallemand P</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Laverdure+S%22">Laverdure S</searchLink>; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Leshnower+BG%22">Leshnower BG</searchLink>; Division of Cardiothoracic Surgery, Emory School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Looney+D%22">Looney D</searchLink>; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Moschopoulos+CD%22">Moschopoulos CD</searchLink>; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Mugerwa+H%22">Mugerwa H</searchLink>; Joint Clinical Research Centre, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Murray+DD%22">Murray DD</searchLink>; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Mylonakis+E%22">Mylonakis E</searchLink>; Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Nagy-Agren+S%22">Nagy-Agren S</searchLink>; Salem Veterans Affairs Medical Center, Virginia, USA.; Virginia Tech Carilion School of Medicine, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Rehman+MT%22">Rehman MT</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Rupert+A%22">Rupert A</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Stevens+RA%22">Stevens RA</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Turville+S%22">Turville S</searchLink>; The Kirby Institute, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Weintrob+A%22">Weintrob A</searchLink>; Infectious Diseases Section, Washington DC Veterans Affairs Medical Center, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Wick+K%22">Wick K</searchLink>; Department of Internal Medicine, University of California Davis, Davis, California, USA.<br /><searchLink fieldCode="AU" term="%22Lundgren+J%22">Lundgren J</searchLink>; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Ko+ER%22">Ko ER</searchLink>; Division of General Internal Medicine, Department of Medicine, Duke University Health System, Durham, North Carolina, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ACTIV-3%2FTICO+Study+Group%22">ACTIV-3/TICO Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2024 Mar 14; Vol. 229 (3), pp. 671-679.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37948759
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiad446
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 671
    Titles:
      – TitleFull: Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jensen TO
      – PersonEntity:
          Name:
            NameFull: Grandits GA
      – PersonEntity:
          Name:
            NameFull: Jain MK
      – PersonEntity:
          Name:
            NameFull: Murray TA
      – PersonEntity:
          Name:
            NameFull: Grund B
      – PersonEntity:
          Name:
            NameFull: Shaw-Saliba K
      – PersonEntity:
          Name:
            NameFull: Matthay MA
      – PersonEntity:
          Name:
            NameFull: Abassi M
      – PersonEntity:
          Name:
            NameFull: Ardelt M
      – PersonEntity:
          Name:
            NameFull: Baker JV
      – PersonEntity:
          Name:
            NameFull: Chen P
      – PersonEntity:
          Name:
            NameFull: Dewar RL
      – PersonEntity:
          Name:
            NameFull: Goodman AL
      – PersonEntity:
          Name:
            NameFull: Hatlen TJ
      – PersonEntity:
          Name:
            NameFull: Highbarger HC
      – PersonEntity:
          Name:
            NameFull: Holodniy M
      – PersonEntity:
          Name:
            NameFull: Lallemand P
      – PersonEntity:
          Name:
            NameFull: Laverdure S
      – PersonEntity:
          Name:
            NameFull: Leshnower BG
      – PersonEntity:
          Name:
            NameFull: Looney D
      – PersonEntity:
          Name:
            NameFull: Moschopoulos CD
      – PersonEntity:
          Name:
            NameFull: Mugerwa H
      – PersonEntity:
          Name:
            NameFull: Murray DD
      – PersonEntity:
          Name:
            NameFull: Mylonakis E
      – PersonEntity:
          Name:
            NameFull: Nagy-Agren S
      – PersonEntity:
          Name:
            NameFull: Rehman MT
      – PersonEntity:
          Name:
            NameFull: Rupert A
      – PersonEntity:
          Name:
            NameFull: Stevens RA
      – PersonEntity:
          Name:
            NameFull: Turville S
      – PersonEntity:
          Name:
            NameFull: Weintrob A
      – PersonEntity:
          Name:
            NameFull: Wick K
      – PersonEntity:
          Name:
            NameFull: Lundgren J
      – PersonEntity:
          Name:
            NameFull: Ko ER
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 03
              Text: 2024 Mar 14
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 229
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1